|
|
Volumn 7, Issue 3, 2002, Pages 156-157
|
|
Arsenic: Carcinogen or cancer therapy?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARSENIC TRIOXIDE;
CARCINOGEN;
DOXORUBICIN;
ENZYME INHIBITOR;
MESSENGER RNA;
REACTIVE OXYGEN METABOLITE;
RETINOIC ACID;
TELOMERASE;
VINCRISTINE;
ANTINEOPLASTIC AGENT;
ARSENIC;
ORGANOARSENIC DERIVATIVE;
OXIDE;
POISON;
CANCER THERAPY;
CARCINOGENESIS;
CELL DEATH;
CELL PROLIFERATION;
CHROMOSOME DAMAGE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TARGETING;
ENZYME ACTIVITY;
GENE EXPRESSION;
GENETIC TRANSCRIPTION;
HUMAN;
LEUKEMIA REMISSION;
MOLECULAR DYNAMICS;
NOTE;
PROMYELOCYTIC LEUKEMIA;
RELAPSE;
ARTICLE;
METABOLISM;
ANTINEOPLASTIC AGENTS;
ARSENIC;
ARSENICALS;
CARCINOGENS;
HUMANS;
OXIDES;
POISONS;
TELOMERASE;
|
|
EID: 0036462466
PISSN: 13596446
EISSN: None
Source Type: Journal
DOI: 10.1016/S1359-6446(01)02157-2 Document Type: Short Survey |
|
Times cited : (7)
|
|
References (2)
|
